Background: Tertiary centre labour and birthing units are characterised by rapid turnover of both staff and complex patients. This may result in a challenging environment for staff whereby they may not be adequately familiar with either patients or members of the team. The link between ineffective handover and poor patient outcomes has been demonstrated 1 . A reduction in rates of adverse events has been seen with implementation of systematic handover tools 1 , providing oncoming teams with information required to establish team and situational awareness. The need for a structured handover tool in our tertiary centre was identified. Methods: The SAFE handover model was introduced to a tertiary labour ward in December 2017, consisting of Staff introductions; patients Awaiting (theatre, induction, epidural or review); Future (patients at risk of deterioration); and Expects (patient transfers). Pre-implementation and 12-month postimplementation audits were performed.
information required to establish team and situational awareness. The need for a structured handover tool in our tertiary centre was identified.
Methods: The SAFE handover model was introduced to a tertiary labour ward in December 2017, consisting of Staff introductions; patients Awaiting (theatre, induction, epidural or review); Future (patients at risk of deterioration); and Expects (patient transfers). Pre-implementation and 12-month postimplementation audits were performed.
Results: Preliminary results have shown significant improvement in staff awareness following implementation. An increase in all areas; correct staff identification increased from 36% to 95%, awareness of patients awaiting care 47.5% to 92%, identification of future patients at risk 64.5% to 95% and awareness of patient expects 71% to 90%.
Conclusions: SAFE had a positive impact on the handover practices on our tertiary labour ward, with significant improvement in situational and team awareness demonstrated. Future assessment of patient outcomes is planned. The Centenary Hospital for Women and Children, Canberra, Australia. Email: dugald.kenny@act.gov.au
Objective: The national core maternity indicator for fetal growth restriction (FGR) is the proportion of babies born ≥40 weeks gestation with birthweight <2750 g. Better detection of FGR is an important national strategy aimed at improving outcomes.
Method: Retrospective audit (1/9/13-31/8/18) of singleton births ≥40-weeks weighing <2750 g at a tertiary level unit.
Results: N = 118 (39 male, 79 female) cases, an incidence of 1.78%(118/6619) of births ≥40 weeks and 0.67%(118/17858) of total births. Symphysis-fundal-height (SFH) measurement was recorded at each visit >24 weeks in 43%(51/118). All women were suitable for serial measurements. FGR had been identified in late pregnancy (39-40 weeks) Background: There is currently no treatment to prevent or reduce the risk of fetal hypoxia in labour. Sildenafil Citrate (SC), via its ability to improve uteroplacental perfusion, could potentially reduce the risk of intrapartum fetal compromise (IFC). The aim of this study was to evaluate if SC reduces the incidence of operative intervention for presumed IFC at term.
Methods: Study performed at the Mater Mother's Hospital in Brisbane between 2015 and 2018. Primary outcome was operative intervention (caesarean or instrumental birth) rates for presumed IFC. Participants received SC or placebo during labour. Fetal heart rate abnormalities were classified according to the RANZCOG guidelines. Only pregnancies with normally grown fetuses were included. The study was not powered to detect differences in neonatal outcomes.
Results: 300 women were recruited. Women in the SC arm were 40% less likely (19.3% vs. 32%, P = 0.01) to develop the primary outcome and less likely (2% vs. 6.7%, P = 0.047) to require intrapartum FBS because of concerns about FHR abnormalities. Rates of meconium stained liquor were lower in the Sildenafil cohort (13.3% vs. 20%, P = 0.12). There were no differences in adverse perinatal or maternal outcomes. Median birth weight was not different (3474.5g vs. 3432, P = 0.71).
Conclusions: In this novel study SC reduces the risk of operative birth for presumed IFC. Further studies are required to ascertain if it could also reduce rates of adverse neonatal outcomes. Our results, raise the possibility of reducing the risk of intrapartum fetal hypoxia using pharmacological means and the potential for mitigating associated perinatal and longer-term complications.
